Kegg Pathway: Calcium signaling pathway

KEGG ID: 04020

Reference Diagram

KEGG Diagram for Calcium signaling pathway

Rat

There are 163 IPI Records from this pathway found in Rattus norvegicus.

Location of Calcium signaling pathway proteins on Rat Genome

IPI Record Position
1: Adcy1_predicted 14:87812093-87923402
2: Adcy2 17:4543509-5039775
3: Adcy3 6:27118400-27202275
4: Adcy4 15:33930534-33946352
5: Adcy7 19:20052391-20091871
6: Adcy8 7:101957807-102210346
7: Adora2a 20:13815719-13834131
8: Adora2b 10:48421592-48437967
9: Adra1a 15:46173408-46263607
10: Adra1b 10:28889639-28946500
11: Adra1d 3:119279974-119295985
12: Adrb1 1:263025655-263027055
13: Adrb2 18:58175545-58176801
14: Adrb3 16:69163620-69166384
15: Agtr1a 17:40629320-40684982
16: Agtr1b 2:105503269-105602591
17: Atp2a1 :-
18: Atp2a2 12:35267106-35316229
19: Atp2a3 10:59853363-59884087
20: Atp2b1 7:36493661-36600280
21: Atp2b2 4:149658814-149764235
22: Atp2b3 X:159400381-159470665
23: Atp2b4 13:46631353-46697047
24: Avpr1a 7:62225553-62229616
25: Avpr1b 13:44537268-44547983
26: Bdkrb1 6:129760129-129762545
27: Bdkrb2 :-
28: Bst1 14:72404699-72414490
29: Cacna1a 19:25188220-25424495
30: Cacna1b 3:2875964-3039665
31: Cacna1c 4:154897217-155517204
32: Cacna1d 16:5383259-5851968
33: Cacna1e 13:69367005-69683936
34: Cacna1f X:26908850-26937165
35: Cacna1g 10:83043636-83112401
36: Cacna1i 7:118582279-118681520
37: Calm3 1:77245748-77248702
38: Camk2a 18:56879142-56948262
39: Camk2b 14:86634690-86721261
40: Camk2d 2:224021416-224106433
41: Camk2g :-
42: Camk4 18:25408043-25626393
43: Cckar :-
44: Cckbr 1:163156914-163166969
45: Cd38 14:72320479-72360329
46: Chp 3:106066389-106101638
47: Chrm1 1:211351738-211353120
48: Chrm2 4:63911336-63912736
49: Chrm3 17:71214893-71218463
50: Chrm5 3:98326973-98328568
51: Chrna7 1:117587580-117716267
52: Cysltr1 X:94802078-94803133
53: Cysltr2 15:53647500-53648429
54: Drd1a 17:16655120-16658949
55: Ednra 19:32046233-32105240
56: Ednrb 15:87893681-87898963
57: Egfr 14:97617358-97788213
58: Erbb2 10:87219085-87242919
59: Erbb3 7:1858057-1877353
60: Erbb4 9:66843998-67967937
61: F2r 2:25987859-25989070
62: Gna11 7:9636748-9662492
63: Gna14 1:219972070-219982070
64: Gna15 7:9669950-9689442
65: Gnal 18:63595606-63735803
66: Gnaq 1:219520998-219764401
67: Gnas 3:165213385-165217627
68: Grin1 3:3453784-3480403
69: Grin2a 10:5590487-6004680
70: Grin2c 10:105323250-105341247
71: Grin2d 1:96309508-96342105
72: Grm1 1:5318617-5744593
73: Grm5 1:143863506-144477283
74: Grpr X:51743239-51783255
75: Hrh1 4:150431239-150432699
76: Hrh2 17:16497967-16499043
77: Htr2a 15:55463338-55533964
78: Htr2b 9:84840003-84852984
79: Htr2c X:31015580-31132215
80: Htr4 18:58417161-58509734
81: Htr5a 4:2707261-2716944
82: Htr5b 13:33545128-33558050
83: Htr6 :-
84: Htr7 1:240134692-240260620
85: Itpka 3:106257482-106266160
86: Itpkb 13:96046063-96138171
87: Itpr1 4:143705360-144030051
88: Itpr2 4:183679958-184065884
89: Itpr3 20:5292430-5357502
90: Lhcgr 6:12614027-12671590
91: Ltb4r2 15:33923472-33924548
92: Mylk2 3:143252234-143262989
93: Mylk_predicted 11:67604357-67782117
94: Nos1 12:39814919-39869383
95: Nos2 10:65036889-65072771
96: Nos3 4:6158847-6179441
97: Ntsr1_predicted 3:169567952-169630928
98: Oxtr 4:148314068-148326827
99: P2rx1 10:59889933-59904987
100: P2rx2 12:46485122-46488319
101: P2rx3 3:68230420-68270570
102: P2rx4 12:34943903-34961492
103: P2rx5 10:60036074-60047683
104: P2rx7 12:35074025-35117152
105: P2rxl1 11:85431257-85441174
106: Pde1a 3:62671556-62928487
107: Pde1b 7:142401489-142427626
108: Pde1c 4:84937137-85447998
109: Pdgfra 14:35369673-35418129
110: Pdgfrb 18:57014475-57053583
111: Phka1 X:90553527-90692073
112: Phkb 19:22373060-22561492
113: Phkg1 12:28029616-28043499
114: Phkg2 1:186857977-186870611
115: Plcb1 3:122799444-123522328
116: Plcb2 3:105197784-105223342
117: Plcb3 1:209628300-209643682
118: Plcb4 3:123861013-124077386
119: Plcd1 8:124023086-124052193
120: Plcd3_predicted 10:92235140-92276697
121: Plcd4 9:73872916-73905127
122: Plce1 1:242794858-243103437
123: Plcg1 3:151522949-151565985
124: Plcg2 19:47875895-47947572
125: Pln 20:32000371-32008559
126: Ppid 2:170995919-171007930
127: Ppp3ca 2:234333405-234408670
128: Ppp3cb 15:4003159-4022737
129: Ppp3cc 15:50616841-50666010
130: Ppp3r1 14:98047333-98131590
131: Ppp3r2 5:66423374-66424371
132: Prkaca 19:25837118-25864844
133: Prkacb 2:244946188-245002604
134: Prkca 10:97361597-97625118
135: Prkcb1 1:181118102-181459480
136: Prkcc 1:64145733-64172745
137: Ptafr 5:152565687-152587342
138: Ptger1 19:26160728-26163156
139: Ptger3 2:255680691-255759202
140: Ptgfr :-
141: Ptk2b 15:45589213-45718044
142: RGD1565338_predicted :-
143: Ryr1 1:84116216-84254639
144: Ryr3 3:98476626-98813129
145: Slc25a4 16:49353476-49357271
146: Slc25a5 X:8072234-8075359
147: Slc8a1 6:4413830-4712275
148: Slc8a2 1:76473938-76647486
149: Slc8a3 6:105012886-105159943
150: Sphk1 10:106643201-106645312
151: Sphk2 1:96178615-96183468
152: Tacr1 4:116610578-116780483
153: Tacr2 :-
154: Tacr3 2:232309015-232404964
155: Tbxa2r 7:9868125-9873543
156: Tnnc1 16:6639357-6642331
157: Tnnc2 3:155807133-155808217
158: Trhr 7:80050706-80096012
159: Trhr2 19:52623036-52628006
160: Trpc1 8:100770837-100821447
161: Vdac1 10:37795721-37823252
162: Vdac2 15:2515295-2528969
163: Vdac3 16:73922950-73939402

Mouse

There are 163 IPI Records from this pathway found in Mus musculus.

Location of Calcium signaling pathway proteins on Mouse Genome

IPI Record Position
1: Adcy1 11:6963492-7078509
2: Adcy2 13:69087426-69466728
3: Adcy3 12:4133468-4214742
4: Adcy4 14:54723163-54738090
5: Adcy7 8:91162508-91220066
6: Adcy8 15:64528707-64751833
7: Adcy9 16:4202773-4335034
8: Adora2a 10:74769509-74778497
9: Adora2b 11:62065179-62082647
10: Adra1a 14:65589368-65687439
11: Adra1b 11:43618029-43744633
12: Adra1d 2:131237291-131253726
13: Adrb1 19:56775622-56777022
14: Adrb2 18:62303865-62305121
15: Adrb3 8:28691712-28695524
16: Agtr1a 13:30343922-30390332
17: Agtr1b 3:20505546-20558250
18: Atp2a1 7:126238017-126254070
19: Atp2a2 5:122703319-122762791
20: Atp2a3 11:72777450-72809234
21: Atp2b1 10:98344858-98453480
22: Atp2b2 6:113711445-114007621
23: Atp2b3 X:69755806-69823725
24: Atp2b4 1:135523057-135569692
25: Avpr1a 10:121851559-121856513
26: Avpr1b 1:133427287-133439546
27: Bdkrb1 12:106005141-106006478
28: Bdkrb2 12:105964222-105994121
29: Bst1 5:44107160-44131495
30: Cacna1a 8:87305750-87530351
31: Cacna1b 2:24425896-24585169
32: Cacna1c 6:118557938-119023135
33: Cacna1d 14:28871082-29320165
34: Cacna1e 1:156158170-156488137
35: Cacna1f X:6764079-6792152
36: Cacna1g 11:94224461-94290190
37: Cacna1h 17:25101887-25161385
38: Cacna1i 15:80222390-80222914
39: Cacna1s 1:137869195-137935939
40: Calm3 12:100601209-100610856
41: Calm4 13:3837002-3837917
42: Calml3 13:3803000-3803449
43: Camk2a 18:61050987-61113521
44: Camk2b 11:5869675-5965751
45: Camk2d 3:126588995-126837076
46: Camk2g 14:19523427-19582640
47: Camk4 18:33082366-33311737
48: Cckar 5:53986735-53996350
49: Cckbr 7:105299638-105344719
50: Cd38 5:44157098-44200622
51: Chrm1 19:8731396-8748612
52: Chrm2 6:36453362-36454762
53: Chrm3 13:9876475-9878244
54: Chrm5 2:112280010-112281608
55: Chrna7 7:62977642-63091519
56: Cysltr1 X:102780539-102781594
57: Cysltr2 14:71764210-71784186
58: D830007F02Rik 8:88214406-88255279
59: Drd1a 13:54061276-54065279
60: Ednra 8:80559103-80620420
61: Ednrb 14:102700304-102729852
62: Egfr 11:16652206-16813912
63: Erbb2 11:98228574-98253806
64: Erbb3 10:127972317-127992450
65: Erbb4 1:67973387-69040964
66: F2r 13:96702488-96719173
67: Gna11 10:80931861-80948175
68: Gna14 19:16502781-16677839
69: Gna15 10:80905439-80927354
70: Gnal 18:67213705-67349624
71: Gnaq 19:16199850-16454472
72: Gnas 2:173927270-173989683
73: Grin1 2:25114256-25140988
74: Grin2a 16:9491382-9906111
75: Grin2c 11:115065259-115083333
76: Grin2d 7:45700822-45734609
77: Grm1 10:10378793-10772495
78: Grm5 7:87477812-88006270
79: Grpr X:158858009-158893752
80: Hrh1 6:114363531-114448891
81: Hrh2 13:54201750-54232053
82: Htr2a 14:73374995-73441014
83: Htr2b 1:87930208-87943141
84: Htr2c X:142208881-142443644
85: Htr4 18:62449573-62593171
86: Htr5a 5:28172734-28185873
87: Htr5b 1:123337304-123355981
88: Htr6 4:138333485-138346865
89: Htr7 19:36025416-36122492
90: IPI00458351 5:97505130-97506026
91: Itpka 2:119433778-119442694
92: Itpkb 1:182168986-182258559
93: Itpr1 6:108178895-108516886
94: Itpr2 6:146068634-146459082
95: Itpr3 17:26785125-26849812
96: Lhcgr 17:88649875-88700302
97: Ltb4r2 14:54715499-54717300
98: Mylk 16:34735182-34920279
99: Mylk2 2:152608869-152614502
100: Nos1 5:118103174-118219870
101: Nos2 11:78737046-78776416
102: Nos3 5:23874884-23894536
103: Ntsr1 2:180429384-180474387
104: Oxtr 6:112442851-112455574
105: P2rx1 11:72815337-72831395
106: P2rx2 5:110580495-110583257
107: P2rx3 2:84797391-84836673
108: P2rx4 5:122968201-122989657
109: P2rx5 11:72976720-72988880
110: P2rx7 5:122904528-122951908
111: P2rxl1 16:17475572-17485574
112: Pde1a 2:79635292-79930314
113: Pde1b 15:103331332-103358086
114: Pde1c 6:55999382-56291970
115: Pdgfra 5:75434033-75479895
116: Pdgfrb 18:61170519-61210428
117: Phka1 X:98718393-98846917
118: Phka2 X:155846795-155935827
119: Phkb 8:88731107-88950754
120: Phkg1 5:130148130-130163787
121: Phkg2 7:127364552-127374453
122: Plcb1 2:134477974-135163721
123: Plcb3 19:7020758-7036804
124: Plcb4 2:135496989-135704509
125: Plcd1 9:118920228-118942200
126: Plcd3 11:102886394-102917748
127: Plcd4 1:74476095-74501001
128: Plce1 19:38589341-38848017
129: Plcg1 2:160422751-160467201
130: Plcg2 8:120384268-120521119
131: Plcz1 6:139952128-140003837
132: Pln 10:53026122-53034396
133: Ppid 3:79677316-79689577
134: Ppp3ca 3:136608220-136874773
135: Ppp3cb 14:19288592-19335096
136: Ppp3cc 14:68953164-69002587
137: Ppp3r1 :-
138: Ppp3r2 4:49699847-49703083
139: Prkaca 8:86863093-86889980
140: Prkacb 3:146666960-146750346
141: Prkca 11:107754338-108159844
142: Prkcb1 7:122080445-122419803
143: Prkcc :-
144: Prkx X:74014742-74048679
145: Ptafr 4:131836299-131852935
146: Ptger1 8:86556973-86562860
147: Ptger3 3:157502185-157580051
148: Ptgfr 3:151737371-151774818
149: Ptk2b 14:65107372-65235162
150: Ryr1 7:28712104-28833911
151: Ryr2 13:11608677-12000036
152: Ryr3 2:112432962-113017829
153: Slc25a4 8:47705991-47709847
154: Slc25a5 X:33227094-33230251
155: Slc8a1 17:81294345-81557933
156: Slc8a2 7:15288682-15319029
157: Slc8a3 12:82118342-82252028
158: Sphk1 11:116348001-116352758
159: Sphk2 7:45578327-45583249
160: Tacr1 6:82368133-82525757
161: Tacr2 10:61648175-61661347
162: Tacr3 3:134766394-134871959
163: Tbxa2r 10:80731957-80738300
164: Tnnc1 14:30037321-30040720
165: Tnnc2 2:164468366-164470946
166: Trhr 15:44027160-44059621
167: Trhr2 8:125243057-125246836
168: Trpc1 9:95515979-95559710
169: Vdac1 11:52204283-52232820
170: Vdac2 14:20620113-20634431
171: Vdac3 8:24042620-24059306

Human

There are 163 IPI Records from this pathway found in Homo sapiens.

Location of Calcium signaling pathway proteins on Human Genome

IPI Record Position
1: ADCY1 7:45580646-45729237
2: ADCY2 5:7449345-7883194
3: ADCY3 2:24895542-24996212
4: ADCY4 14:23857395-23874117
5: ADCY7 16:48879323-48909536
6: ADCY8 8:131861736-132123854
7: ADCY9 16:3952658-4106187
8: ADORA2A 22:23153537-23168309
9: ADORA2B 17:15788956-15819935
10: ADRA1A 8:26661584-26778839
11: ADRA1B 5:159276318-159332595
12: ADRA1D 20:4149329-4177659
13: ADRB1 10:115793796-115796657
14: ADRB2 5:148185001-148188447
15: ADRB3 8:37939673-37943341
16: AGTR1 3:149898355-149943478
17: ATP2A1 16:28797310-28823331
18: ATP2A2 12:109203815-109273278
19: ATP2A3 17:3773918-3814485
20: ATP2B1 12:88505959-88573975
21: ATP2B2 3:10340707-10724716
22: ATP2B3 X:152436328-152501591
23: ATP2B4 1:201862312-201979832
24: AVPR1A 12:61826483-61832857
25: AVPR1B 1:204390599-204398262
26: BDKRB1 14:95799760-95800847
27: BDKRB2 14:95740950-95780536
28: BST1 4:15313738-15343508
29: CACNA1A 19:13179088-13478038
30: CACNA1B 9:139892062-140138897
31: CACNA1C 12:2094650-2670626
32: CACNA1D 3:53503723-53821112
33: CACNA1E 1:179648918-180037339
34: CACNA1F X:48948467-48976777
35: CACNA1G 17:45993820-46059541
36: CACNA1H 16:1143739-1211772
37: CACNA1I 22:38296704-38415681
38: CACNA1S 1:199275265-199348317
39: CALM3 19:51796352-51805878
40: CALML3 10:5555972-5558734
41: CALML6 1:1836126-1838595
42: CAMK2A 5:149582736-149649485
43: CAMK2B 7:44225422-44331749
44: CAMK2D 4:114593022-114902177
45: CAMK2G 10:75242265-75304349
46: CAMK4 5:110587968-110858483
47: CCKAR 4:26092116-26101140
48: CCKBR 11:6237542-6249932
49: CD38 4:15388999-15460167
50: CHP 15:39310729-39361369
51: CHRM1 11:62432728-62445588
52: CHRM2 7:136203956-136355539
53: CHRM3 1:237859012-238145373
54: CHRM5 15:32142129-32144579
55: CHRNA7 15:30110018-30248525
56: CYSLTR1 X:77413617-77469636
57: CYSLTR2 13:48178692-48181499
58: DRD1 5:174800643-174803769
59: EDNRA 4:148621575-148685555
60: EDNRB 13:77367617-77391904
61: EGFR 7:55054219-55242524
62: ERBB2 17:35104766-35138441
63: ERBB3 12:54760159-54783395
64: ERBB4 2:211956585-213111499
65: F2R 5:76047542-76067054
66: GNA11 19:3072508-3074793
67: GNA14 9:79227815-79453043
68: GNA15 19:3087230-3114741
69: GNAL 18:11679263-11871921
70: GNAQ 9:79520823-79836194
71: GNAS 20:56848168-56919642
72: GRIN1 9:139152663-139183028
73: GRIN2A 16:9764507-10181769
74: GRIN2C 17:70349757-70367602
75: GRIN2D 19:53589944-53639205
76: GRM1 6:146390611-146800427
77: GRM5 11:87881006-88420838
78: GRPR X:16051345-16081562
79: HRH1 3:11275687-11279415
80: HRH2 5:175017637-175045847
81: HTR2A 13:46305514-46368179
82: HTR2B 2:231681199-231698068
83: HTR2C X:113724807-114050880
84: HTR4 5:147810872-148013909
85: HTR5A 7:154492967-154508392
86: HTR6 1:19864367-19878642
87: HTR7 10:92490558-92607651
88: ITPKA 15:39573365-39583035
89: ITPKB 1:224886016-224993647
90: ITPR1 3:4510136-4863432
91: ITPR2 12:26381609-26877347
92: ITPR3 6:33696500-33772329
93: LHCGR 2:48768340-48836314
94: LTB4R2 14:23838908-23855990
95: MLCK 16:45298960-45339722
96: MYLK 3:124813835-125085839
97: MYLK2 20:29870822-29886174
98: NOS1 12:116135362-116283965
99: NOS2A 17:23107922-23151682
100: NOS3 7:150319080-150342608
101: NTSR1 20:60810634-60864568
102: OXTR 3:8765419-8786300
103: P2RX1 17:3746640-3766709
104: P2RX2 12:131705476-131709045
105: P2RX3 11:56862525-56894125
106: P2RX4 12:120132043-120156290
107: P2RX7 12:120055061-120108239
108: P2RXL1 22:19699449-19713119
109: PDE1A 2:182720051-183095348
110: PDE1B 12:53229671-53259290
111: PDE1C 7:31759215-32304872
112: PDGFRA 4:54790204-54859171
113: PDGFRB 5:149473598-149515615
114: PHKA1 X:71715389-71850892
115: PHKA2 X:18820339-18912637
116: PHKB 16:46052739-46291657
117: PHKG1 7:56115471-56128121
118: PHKG2 16:30667238-30676183
119: PLCB1 20:8060908-8813547
120: PLCB2 15:38367402-38387330
121: PLCB3 11:63775623-63791970
122: PLCB4 20:9024932-9409889
123: PLCD1 3:38023993-38046137
124: PLCD3 17:40544544-40565407
125: PLCD4 2:219180866-219210140
126: PLCE1 10:95743736-96078136
127: PLCG1 20:39199291-39237775
128: PLCG2 16:80370408-80549399
129: PLCZ1 12:18727379-18782216
130: PLN 6:118976154-118988586
131: PPID 4:159849730-159864002
132: PPP3CA 4:102163610-102487376
133: PPP3CB 10:74866192-74925765
134: PPP3CC 8:22354541-22454580
135: PPP3R1 :-
136: PPP3R2 9:103393718-103397104
137: PRKACA 19:14063509-14089559
138: PRKACB 1:84316329-84476769
139: PRKACG 9:70817241-70818849
140: PRKCA 17:61729388-62237324
141: PRKCB1 16:23754823-24139358
142: PRKCG 19:59077279-59102713
143: PRKX X:3532415-3641661
144: PRKY Y:7202013-7309589
145: PTAFR 1:28346264-28392971
146: PTGER1 19:14444279-14447174
147: PTGER3 1:71090624-71286079
148: PTGFR 1:78542156-78778022
149: PTK2B 8:27238971-27372824
150: RP11-145H9.1 6:2608871-2696153
151: RYR1 19:43616180-43770012
152: RYR2 1:235272128-236063911
153: RYR3 15:31545225-31945594
154: SLC25A4 4:186301392-186305418
155: SLC25A5 X:118486435-118489386
156: SLC25A6 X:1465045-1471617
157: SLC8A1 2:40192790-40534188
158: SLC8A2 19:52623735-52666934
159: SLC8A3 14:69582417-69725343
160: SPHK1 17:71892326-71895530
161: SPHK2 19:53814360-53825473
162: TACR1 2:75129738-75279781
163: TACR2 10:70833665-70846629
164: TACR3 4:104730074-104860422
165: TBXA2R 19:3545778-3557658
166: TNNC1 3:52460158-52463098
167: TNNC2 20:43885260-43895791
168: TRHR 8:110168900-110200989
169: TRPC1 3:143925603-144009415
170: TTN 2:179099985-179380394
171: VDAC1 5:133335506-133368723
172: VDAC2 10:76640515-76661212
173: VDAC3 8:42368547-42382568

Google Scholar

Recent Literature

Calcium-Dependent Increases in Protein Kinase-A Activity in Mouse Retinal Ganglion Cells Are Mediated by Multiple Adenylate Cyclases.

PLoS One. 2009; 4(11): e7877
Dunn TA, Storm DR, Feller MB

Neurons undergo long term, activity dependent changes that are mediated by activation of second messenger cascades. In particular, Calcium-dependent activation of the cyclic-AMP/Protein kinase A signaling cascade has been implicated in several developmental processes including cell survival, axonal outgrowth, and axonal refinement. The biochemical link between Calcium influx and the activation of the cAMP/PKA pathway is primarily mediated through adenylate cyclases. Here, dual imaging of intracellular Calcium concentration and PKA activity was used to assay the role of different classes of Calcium-dependent adenylate cyclases (ACs) in the activation of the cAMP/PKA pathway in retinal ganglion cells (RGCs). Surprisingly, depolarization-induced Calcium-dependent PKA transients persist in barrelless mice lacking AC1, the predominant Calcium-dependent adenylate cyclase in RGCs, as well as in double knockout mice lacking both AC1 and AC8. Furthermore, in a subset of RGCs, depolarization-induced PKA transients persist during the inhibition of all transmembrane adenylate cyclases. These results are consistent with the existence of a soluble adenylate cyclase that plays a role in Calcium-dependent activation of the cAMP/PKA cascade in neurons.

PI(4,5)P2 and loss of PLC{gamma} activity inhibit TRPM channels required for oscillatory Ca2+ signaling.

Am J Physiol Cell Physiol. 2009 Nov 18;
Xing J, Strange K

The C. elegans intestinal epithelium generates rhythmic inositol 1,4,5-trisphosphate (IP3)-dependent Ca(2+) oscillations that control muscle contractions required for defecation. Two highly Ca(2+) selective TRPM channels, GON-2 and GTL-1, function with PLCgamma in a common signaling pathway that regulates IP(3)-dependent intracellular Ca(2+) release. A second PLC, PLCgamma, is also required for IP3-dependent Ca(2+) oscillations, but functions in an independent signaling mechanism. PLCgamma generates IP(3) that regulates IP3 receptor activity. We demonstrate here that PLCgamma via hydrolysis of PI(4,5)P2 (PIP(2)) also regulates GON-2/GTL-1 function. Knockdown of PLCgamma but not PLCgamma activity by RNA interference (RNAi) inhibits channel activity ~80%. Inhibition is fully reversed by agents that deplete PIP(2) levels. PIP(2) added to the patch pipette has no effect on channel activity in PLCgamma RNAi cells. However, in control cells, 10 muM PIP(2) inhibits whole cell current ~80%. Channel inhibition by phospholipids is selective for PIP(2) with an IC50 value of 2.6 muM. Elevated PIP2 levels have no effect on channel voltage and Ca(2+) sensitivity and likely inhibit by reducing channel open probability, single channel conductance and/or trafficking. We conclude that hydrolysis of PIP(2) by PLCgamma functions in the activation of both the IP(3) receptor and GON-2/GTL-1 channels. GON-2/GTL-1 functions as the major intestinal cell Ca(2+) influx pathway. Calcium influx through the channel feedback regulates its activity and likely functions to modulate IP(3) receptor function. PIP(2)-dependent regulation of GON-2/GTL-1 may provide a mechanism to coordinate plasma membrane Ca(2+) influx with PLCgamma and IP(3) receptor activity as well as intracellular Ca(2+) store depletion.

Development of an Improved IP(1) Assay for the Characterization of 5-HT(2C) Receptor Ligands.

Assay Drug Dev Technol. 2009 Nov 18;
Zhang JY, Kowal DM, Nawoschik SP, Dunlop J, Pausch MH, Peri R

The 5-hydroxytryptamine 2C (5-HT(2C)) receptor is a member of the serotonin 5-HT(2) subfamily of G-protein-coupled receptors signaling predominantly via the phospholipase C (PLC) pathway. Stimulation of phosphoinositide (PI) hydrolysis upon 5-HT(2C) receptor activation is traditionally assessed by measuring inositol monophosphate (IP(1)) using time-consuming and labor-intensive anion exchange radioactive assays. In this study, we have developed and optimized a cellular IP(1) assay using homogeneous time-resolved fluorescence (HTRF), a fluorescence resonance energy transfer (FRET)-based technology (Cisbio; Gif sur Yvette, France). The measurement is simple to carry out without the cumbersome steps associated with radioactive assays and may therefore be used as an alternative tool to evaluate PI hydrolysis activated by 5-HT(2C) agonists. In Chinese hamster ovary (CHO) cells stably expressing 5-HT(2C) receptors, characterization of 5-HT(2C) agonists with the HTRF platform revealed a rank order of potency (EC(50), nM) comparable to that from intracellular Calcium mobilization studies measured by the fluorometric imaging plate reader (FLIPR). A similar rank order of potency was seen with conventional radioactive PI assay with the exception of 5-HT. Lastly, the new assay data correlated better with agonist-induced Calcium responses in FLIPR (R(2) = 0.78) than with values determined by radioactive IP(1) method (R(2) = 0.64). Our study shows that the HTRF FRET-based assay detects IP(1) with good sensitivity and may be streamlined for high-throughput (HTS) applications.

Calcium-Independent Phospholipase A2{beta}-Akt signaling Is Involved in Lipopolysaccharide-Induced NADPH Oxidase 1 Expression and Foam Cell Formation.

J Immunol. 2009 Dec 1; 183(11): 7497-7504
Lee SH, Park DW, Park SC, Park YK, Hong SY, Kim JR, Lee CH, Baek SH

Foam cell formation is the most important process in atherosclerosis, and low density lipoprotein oxidation by reactive oxygen species (ROS) is the key step in the conversion of macrophages to foam cells. This study reveals the control mechanism of the gene for NADPH oxidase 1 (Nox1), which produces ROS in the formation of foam cells by stimulating TLR4. Treatment of macrophages by the TLR4 agonist LPS stimulated ROS production and ROS-mediated macrophage to foam cell conversion. This LPS-induced ROS production and foam cell formation could be abrogated by pretreatment of macrophages with N-acetyl cysteine or apocynin. LPS increased Nox1 promoter activity, and resultant expression of mRNA and protein. Small interfering RNA mediated inhibition of Nox1 expression decreased LPS-induced ROS production and foam cell formation. LPS-mediated Nox1 expression and the responses occurred in a Calcium-independent phospholipase A(2) (iPLA(2))-dependent manner. The iPLA(2)beta-specific inhibitor S-BEL or iPLA(2)beta small interfering RNA attenuated LPS-induced Nox1 expression, ROS production, and foam cell formation. In addition, activation of iPLA(2)beta by LPS caused Akt phosphorylation and was followed by increased Nox1 expression. These results suggest that the binding of LPS and TLR4 increases Nox1 expression through the iPLA(2)beta-Akt signaling pathway, and control ROS production and foam cell formation.

Hematopoietic Lineage Cell-Specific Protein 1 Is Recruited to the Immunological Synapse by IL-2-Inducible T Cell Kinase and Regulates Phospholipase C{gamma}1 Microcluster Dynamics during T Cell Spreading.

J Immunol. 2009 Dec 1; 183(11): 7352-7361
Carrizosa E, Gomez TS, Labno CM, Klos Dehring DA, Liu X, Freedman BD, Billadeau DD, Burkhardt JK

Productive T cell activation requires efficient reorganization of the actin cytoskeleton. We showed previously that the actin-regulatory protein, hematopoietic lineage cell-specific protein 1 (HS1), is required for the stabilization of F-actin and Vav1 at the immunological synapse and for efficient Calcium responses. The Tec family kinase IL-2-inducible T cell kinase (Itk) regulates similar aspects of T cell activation, suggesting that these proteins act in the same pathway. Using video microscopy, we show that T cells lacking Itk or HS1 exhibited similar defects in actin responses, extending unstable lamellipodial protrusions upon TCR stimulation. HS1 and Itk could be coimmunoprecipitated from T cell lysates, and GST-pulldown studies showed that Itk's Src homology 2 domain binds directly to two phosphotyrosines in HS1. In the absence of Itk, or in T cells overexpressing an Itk Src homology 2 domain mutant, HS1 failed to localize to the immunological synapse, indicating that Itk serves to recruit HS1 to sites of TCR engagement. Because Itk is required for phospholipase C (PLC)gamma1 phosphorylation and Calcium store release, we examined the Calcium signaling pathway in HS1(-/-) T cells in greater detail. In response to TCR engagement, T cells lacking HS1 exhibited diminished Calcium store release, but TCR-dependent PLCgamma1 phosphorylation was intact, indicating that HS1's role in Calcium signaling is distinct from that of Itk. HS1-deficient T cells exhibited defective cytoskeletal association of PLCgamma1 and altered formation of PLCgamma1 microclusters. We conclude that HS1 functions as an effector of Itk in the T cell actin-regulatory pathway, and directs the spatial organization of PLCgamma1 signaling complexes.

Systemic Analysis of Tumor Cell-Induced Endothelial Calcium signaling and Junction Disassembly.

Cell Mol Bioeng. 2009 Sep 1; 2(3): 375-385
Peng HH, Dong C

It has been shown in our previous study that melanoma cells induce junction disassembly in the manner related to phospholipase C-Calcium activation. In light of this observation, we have developed a mathematical model of the signaling pathway and adapted multi-parametric sensitivity analysis (MPSA) to identify important parameters in the model, which examines tumor cell-induced Calcium mobilization in endothelial cells. The objective functions, with respect to individual parameters, were generated for the Calcium mobilization model and MPSA was performed according to the function. The results showed that sarco/endoplasmic reticulum Calcium ATPase was one of the putative key factors in regulating Calcium mobilization. The model is a proof of concept of systemic analysis of a signaling network, and the results may have practical applications in describing how endothelial cells respond to tumor cells. Taken together, we have devised numerical means to macroscopically study roles of Calcium signaling in endothelial cells in contact with metastatic tumor cells.

Calcineurin Activates Interleukin-6 Transcription in Mouse Skeletal Muscle In Vivo and in C2C12 Myotubes In Vitro.

Am J Physiol Regul Integr Comp Physiol. 2009 Nov 11;
Allen DL, Uyenishi J, Cleary AS, Mehan RS, Lindsay SF, Reed JM

Expression of the cytokine interleukin-6 (IL-6) by skeletal muscle is hugely increased in response to a single bout of endurance exercise, and this appears to be mediated by increases in intracellular Calcium. We examined the effects of endurance exercise on IL-6 mRNA levels and promoter activity in skeletal muscle in vivo, and the role of the Calcium-activated calcineurin signaling pathway on muscle IL-6 expression in vivo and in vitro. IL-6 mRNA levels in the mouse tibialis anterior (TA) were increased 2-10-fold by a single bout of treadmill exercise or by 3 days of voluntary wheel running. Moreover, an IL-6 promoter-driven luciferase transgene was activated in TA by both treadmill and wheel running exercise and by injection with a calcineurin plasmid. Exercise also increased muscle mRNA expression of the calcineurin regulatory gene MCIP1, as did treatment of C2C12 myotubes with the Calcium ionophore A23187. Co-transfection of C2C12 myotubes with a constitutively active calcineurin construct significantly increased while co-transfection with the calcineurin inhibitor CAIN inhibited activity of a mouse IL-6 promoter-reporter construct. Co-transfection with a MEF-2C expression construct increased basal IL-6 promoter activity and augmented the effects of calcineurin co-transfection, while co-transfection with the MEF-2 antagonist MITR repressed calcineurin-activated IL-6 promoter activity in vitro. Surprisingly, co-transfection with a dominant negative form of another calcineurin-activated transcription factor, NFAT, greatly potentiated both basal and calcineurin-stimulated IL-6 promoter activity in C2C12 myotubes. Mutation of the MEF-2 DNA binding sites attenuated while mutation of the NFAT DNA binding sites potentiated basal and calcineurin-activated IL-6 promoter activity. Finally, CREB and C/EBP were necessary for basal IL-6 promoter activity and sufficient to increase IL-6 promoter activity but had minimal roles in calcineurin-activated IL-6 promoter activity. Together these results suggest that IL-6 transcription in skeletal muscle cells can be activated by a calcineurin-MEF-2 axis which is antagonized by NFAT. Key words: transcription, exercise, cytokine, treadmill.

Heteromerization of dopamine D2 receptors with dopamine D1 or D5 receptors generates intracellular Calcium signaling by different mechanisms.

Curr Opin Pharmacol. 2009 Nov 6;
Hasbi A, O'Dowd BF, George SR

The repertoire of signal transduction pathways activated by dopamine in brain includes the increase of intracellular Calcium. However the mechanism(s) by which dopamine activated this important second messenger system was/were unknown. Although we showed that activation of the D5 dopamine receptor increased Calcium concentrations, the restricted anatomic distribution of this receptor made this unlikely to be the major mechanism in brain. We have identified novel heteromeric dopamine receptor complexes that are linked to Calcium signaling. The Calcium pathway activated through the D1-D2 receptor heteromer involved coupling to Gq, through phospholipase C and IP(3) receptors to result in a rise in intracellular Calcium. The Calcium rise activated through the D2-D5 receptor heteromer involved a small rise in intracellular Calcium through the Gq pathway that triggered a store-operated channel mediated influx of extracellular Calcium. These novel receptor heteromeric complexes, for the first time, establish the link between dopamine action and rapid Calcium signaling.

Cyclic loading opens hemichannels to release ATP as part of a chondrocyte mechanotransduction pathway.

J Orthop Res. 2009 Nov 4;
Garcia M, Knight MM

The process of chondrocyte mechanotransduction is poorly understood. However, recent studies suggest the involvement of a purinergic Calcium signaling pathway although the mechanism of ATP release has not been identified. The present study tests the hypothesis that cyclic compression opens hemichannels thereby triggering the release of ATP into the extracellular milieu activating P2 receptors. The well-established chondrocyte-agarose model was utilized enabling chondrocytes to be subjected to a 40-min period of cyclic compression at 0-15% strain and 1 Hz. The opening of hemichannels was determined using Lucifer yellow (LY) incorporation and fluorescence microscopy, whereas the release of ATP into the surrounding media was quantified using the luciferin-luciferase assay. Results indicated that cyclic compression activated hemichannels such that the percentage of cells showing LY incorporation increased from 50 to 70%. This was associated with a sevenfold increase in the release of ATP. Both LY incorporation and ATP release in response to mechanical loading were blocked by the hemichannel inhibitor, flufenamic acid. Treatment with apyrase or P2 receptor antagonists, suramin or oxidated-ATP, did not prevent the mechanically induced response. In conclusion, mechanical loading triggers release of ATP via hemichannels. Hence, this study provides the first evidence of hemichannel involvement in chondrocyte mechanobiology. (c) 2009 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res.

Common and Unique Biological pathways Associated with Smoking Initiation/Progression, Nicotine Dependence, and Smoking Cessation.

Neuropsychopharmacology. 2009 Nov 4;
Wang J, Li MD

Twin and family studies reveal a significant genetic contribution to the risk of smoking initiation and progression (SI/P), nicotine dependence (ND), and smoking cessation (SC). Further, numerous genes have been implicated in these smoking-related behaviors, especially for ND. However, no study has presented a comprehensive and systematic view of the genetic factors associated with these important smoking-related phenotypes. By reviewing the literature on these behaviors, we identified 16, 99, and 75 genes that have been associated with SI/P, ND, and SC, respectively. We then determined whether these genes were enriched in pathways important in the neuronal and brain functions underlying addiction. We identified 9, 21, and 13 pathways enriched in the genes associated with SI/P, ND, and SC, respectively. Among these pathways, four were common to all of the three phenotypes, that is, Calcium signaling, cAMP-mediated signaling, dopamine receptor signaling, and G-protein-coupled receptor signaling. Further, we found that serotonin receptor signaling and tryptophan metabolism pathways were shared by SI/P and ND, tight junction signaling pathway was shared by SI/P and SC, and gap junction, neurotrophin/TRK signaling, synaptic long-term potentiation, and tyrosine metabolism were shared between ND and SC. Together, these findings show significant genetic overlap among these three related phenotypes. Although identification of susceptibility genes for smoking-related behaviors is still in an early stage, the approach used in this study has the potential to overcome the hurdles caused by factors such as genetic heterogeneity and small sample size, and thus should yield greater insights into the genetic mechanisms underlying these complex phenotypes.Neuropsychopharmacology advance online publication, 4 November 2009; doi:10.1038/npp.2009.178.

Cadmium Induces Intracellular Ca2+- and H2O2-dependent Apoptosis through JNK- and p53-mediated pathways in Skin Epidermal Cell line.

Toxicol Sci. 2009 Nov 3;
Son YO, Lee JC, Hitron JA, Pan J, Zhang Z, Shi X

Cadmium is a toxic heavy metal and has been widely used in industry. The skin is an important target for this metal. The mechanisms by which cadmium leads to damage to the skin are unclear at present. The aims of this study were to examine whether cadmium induces apoptosis in mouse skin epidermal cell line, JB6 Cl41 cells, and to investigate the cellular mechanisms by which cadmium causes cytotoxicity in the cells. The present study showed that cadmium induced cell death by apoptosis in a dose-dependent manner, as proven by the appearance of cell shrinkage, the increase of Annexin V-positively stained cells, and the formation of nuclear DNA ladders. Cadmium-induced apoptosis involved a mitochondria-mediated mechanism but not caspase-dependent pathway, in that the critical apoptotic events induced by cadmium, such as the decrease of Bcl-2/Bcl-xL, the increase of GADD45alpha, and the nuclear translocation of AIF, were not affected by the inhibition of executive caspases. In contrast, blockage of p53 and JNK by pharmacological inhibitors or si-RNA transfection suppressed the cadmium-induced apoptosis with the concomitant inhibition of anti-apoptotic Bcl-2 family proteins and GADD45alpha, respectively. Further, the activation of p53 and JNK and their downstream proteins in cadmium-exposed cells were inhibited by individual treatment with catalase and Bapta-AM. These results suggest that cadmium induces apoptosis via the activation of JNK- and p53-mediated signaling, where Calcium ion and hydrogen peroxide act as the pivotal mediators of the apoptotic signaling.

{alpha}5{beta}1 integrin engagement increases BK channel current and Ca2+ sensitivity through c-Src mediated channel phosphorylation.

J Biol Chem. 2009 Nov 3;
Yang Y, Wu X, Gui P, Wu J, Sheng JZ, Ling S, Braun AP, Davis GE, Davis MJ

Large conductance, Calcium-activated K+ (BK) channels are important regulators of cell excitability and recognized targets of intracellular kinases. BK channel modulation by tyrosine kinases, including focal adhesion kinase and c-Src, suggests their potential involvement in integrin signaling. Recently, we found that fibronectin, an endogenous alpha5beta1 integrin ligand, enhances BK channel current through both Ca2+ and phosphorylation-dependent mechanisms in vascular smooth muscle. Here, we show that macroscopic currents from HEK 293 cells expressing murine BK channel alpha-subunits (mSlo) are acutely potentiated following alpha5beta1 integrin activation. The effect occurs in a Ca2+-dependent manner, 1-3 min after integrin engagement. After integrin activation, normalized conductance-voltage relations for mSlo are left-shifted at free Ca2+ concentrations >/= 1 muM. Overexpression of human c-Src with mSlo, in the absence of integrin activation, leads to similar shifts in mSlo Ca2+ sensitivity, whereas overexpression of catalytically inactive c-Src blocks integrin-induced potentiation. However, neither integrin activation nor c-Src overexpression potentiates current in BK channels containing a point mutation at Tyr766. Biochemical tests confirm the critical importance of residue Tyr766 in integrin-induced channel phosphorylation. Thus, BK channel activity is enhanced by alpha5beta1 integrin activation, likely through an intracellular signaling pathway involving c-Src phosphorylation of the channel alpha-subunit at Tyr766. The net result is increased current amplitude, enhanced Ca2+ sensitivity and rate of activation of the BK channel, which would collectively promote smooth muscle hyperpolarization in response to integrin-extracellular matrix interactions.

Orexin A-induced extracellular Calcium influx in prefrontal cortex neurons involves L-type Calcium channels.

J Physiol Biochem. 2009 Jun; 65(2): 125-36
Xia JX, Fan SY, Yan J, Chen F, Li Y, Yu ZP, Hu ZA

Orexins, novel excitatory neuropeptides from the lateral hypothalamus, have been strongly implicated in the regulation of sleep and wakefulness. In this study, we explored the effects and mechanisms of orexin A on intracellular free Ca2+ concentration ([Ca2+]i) of freshly dissociated neurons from layers V and VI in prefrontal cortex (PFC). Changes in [Ca2+]i were measured with fluo-4/AM using confocal laser scanning microscopy. The results revealed that application of orexin A (0.1-1 microM) induced increase of [Ca2+]i in a dose-dependent manner. This elevation of [Ca2+]i was completely blocked by pretreatment with selective orexin receptor 1 antagonist SB 334867. While depletion of intracellular Ca2+ stores by the endoplasmic reticulum inhibitor thapsigargin (2 pM), [Ca2+]i in PFC neurons showed no increase in response to orexin A. Under extracellular Ca2+-free condition, orexin A failed to induce any changes of Ca2+ fluorescence intensity in these acutely dissociated cells. Our data further demonstrated that the orexin A-induced increase of [Ca2+]i was completely abolished by the inhibition of intracellular protein kinase C or phospholipase C activities using specific inhibitors, BIS II (1 microM) and D609 (10 microM), respectively. Selective blockade of L-type Ca2+ channels by nifedipine (5 microM) significantly suppressed the elevation of [Ca2+]i induced by orexin A. Therefore, these findings suggest that exposure to orexin A could induce increase of [Ca2+]i in neurons from deep layers of PFC, which depends on extracellular Ca2+ influx via L-type Ca2+ channels through activation of intracellular PLC-PKC signaling pathway by binding orexin receptor 1.

Modeling species-specific diacylglycerol dynamics in the RAW 264.7 macrophage.

J Theor Biol. 2009 Oct 31;
Callender HL, Horn MA, Decamp DL, Sternweis PC, Alex Brown H

A mathematical model of the G protein signaling pathway in RAW 264.7 macrophages downstream of P2Y(6) receptors activated by the ubiquitous signaling nucleotide uridine 5'-diphosphate is developed. The model, which is based on time-course measurements of inositol trisphosphate, cytosolic Calcium, and diacylglycerol, focuses particularly on differential dynamics of multiple chemical species of diacylglycerol. When using the canonical pathway representation, the model predicted that key interactions were missing from the current network structure. Indeed, the model suggested that accurate depiction of experimental observations required an additional branch to the signaling pathway. An intracellular pool of diacylglycerol is immediately phosphorylated upon stimulation of an extracellular receptor for uridine 5'-diphosphate and subsequently used to aid replenishment of phosphatidylinositol. As a result of sensitivity analysis of the model parameters, key predictions can be made regarding which of these parameters are the most sensitive to perturbations and are therefore most responsible for output uncertainty.

Rosuvastatin inhibits norepinephrine-induced cardiac hypertrophy via suppression of G(h).

Eur J Pharmacol. 2009 Oct 30;
Choi EY, Chang W, Lim S, Song BW, Cha MJ, Kim HJ, Choi E, Jang Y, Chung N, Hwang KC

Statins have recently been shown to produce anti-cardiac hypertrophic effects via the regulation of small GTPases. However, the effects of statins on G protein-mediated cardiac hypertrophy, which is the main pathway of cardiac hypertrophy, have not yet been studied. We sought to evaluate whether statin treatment directly suppresses cardiac hypertrophy through a large G protein-coupled pathway regardless of the regulation of small GTPases. Using neonatal rat cardiomyocytes, we evaluated norepinephrine-induced cardiac hypertrophy for suppressibility of rosuvastatin and the pathways involved by analyzing total protein/DNA content, cell surface area, immunoblotting and RT-PCR for the signal transduction molecule. In a concentration-dependent manner, rosuvastatin inhibited total protein synthesis and downregulated basal and norepinephrine-induced expressions of myosin light chain2 and the c-fos proto-oncogene in cardiomyocytes. Treatment with norepinephrine induced cardiac hypertrophy accompanied by G(h) expression and membrane translocation. Rosuvastatin inhibited G(h) protein activity in cardiomyocytes by inhibiting basal and norepinephrine-stimulated mRNA transcription, protein expression and membrane translocation; however, norepinephrine-stimulated G(q) protein expression was not inhibited. In addition, the norepinephrine-stimulated protein kinase C (PKC)-mitogen-activated protein kinase (MEK 1,2)-extracellular signal-regulated kinases (ERKs) signaling cascade was inhibited by pretreatment with rosuvastatin. Rosuvastatin treatment also helped maintain expression levels of SERCA2a and intracellular Calcium concentration. G(h) protein is a novel target of statins in myocardial hypertrophy, and statin treatment may directly suppress cardiac hypertrophy through a large G(h) protein-coupled pathway regardless of the regulation of small GTPases.

Inhibition of neuronal cell death after retinoic acid-induced down-regulation of P2X(7) nucleotide receptor expression.

Mol Cell Biochem. 2009 Nov 1;
Orellano EA, Rivera OJ, Chevres M, Chorna NE, González FA

Apoptosis is a major mechanism for cell death in the nervous system during development. P2X(7) nucleotide receptors are ionotropic ATP receptors that mediate cell death under pathological conditions. We developed an in vitro protocol to investigate the expression and functional responses of P2X(7) nucleotide receptors during retinoic acid (RA)-induced neuronal differentiation of human SH-SY5Y neuroblastoma cells. Neuronal differentiation was examined measuring cellular growth arrest and neuritic processes elongation. We found that SH-SY5Y cells treated for 5 days with RA under low serum content exhibited a neuron-like phenotype with neurites extending more than twice the length of the cell body and cell growth arrest. Concurrently, we detected the abolishment of intracellular-free Calcium mobilization and the down-regulation of P2X(7) nucleotide receptor protein expression that protected differentiated cells from neuronal cell death and reduced caspase-3 cleavage-induced by P2X(7) nucleotide receptor agonist. The role of P2X(7) nucleotide receptors in neuronal death was established by selectively antagonizing the receptor with KN-62 prior to its activation. We assessed the involvement of protein kinases and found that p38 signaling was activated in undifferentiated after nucleotide stimulation, but abolished by the differentiating RA pretreatment. Importantly, P2X(7) receptor-induced caspase-3 cleavage was blocked by the p38 protein kinase specific inhibitor PD169316. Taken together, our results suggest that RA treatment of human SH-SY5Y cells leads to decreased P2X(7) nucleotide receptor protein expression thus protecting differentiated cells from extracellular nucleotide-induced neuronal death, and p38 signaling pathway is critically involved in this protection of RA-differentiated cells.

C-terminal deletion of metabotropic glutamate receptor 1 selectively abolishes coupling to Galphaq.

Eur J Pharmacol. 2009 Oct 30;
Kammermeier PJ

Recent studies indicate that the intracellular C-terminus of Group I metabotropic glutamate receptors (mGlu(1) and mGlu(5) receptor) is important in G protein coupling. To determine the necessity of the C-tail, a deletion mutant of mGlu(1) receptor was constructed, which included the first 840 amino acids of the rat mGlu(1a) receptor (mGlu(1)-dCT). G protein coupling of the receptors was assessed by measuring glutamate mediated inhibition of native Calcium currents when each receptor was expressed in isolated sympathetic neurons from the rat superior cervical ganglion. Wild type mGlu(1) receptor activates both the Galpha(i/o) and Galpha(q/11) protein families. Each pathway can be detected in superior cervical ganglion neurons as voltage dependent and voltage independent inhibition of the Calcium currents, respectively. While wild type mGlu(1) receptor gave rise to a strong, mixed voltage dependent and independent Calcium current inhibition, mGlu(1)-dCT exhibited a weaker inhibition that was strongly voltage dependent, indicating activation of Galpha(i/o) was predominant. Further, pertussis toxin treatment reduced the inhibition by wild type mGlu(1) receptor to a smaller, voltage independent inhibition as expected, but completely abolished signaling through mGlu(1)-dCT. Finally, to test whether mGlu(1)-dCT could produce any activation of Galpha(q/11), inhibition of the native superior cervical ganglion M-type potassium currents was examined. M-channels, inhibited by PIP(2) depletion, were strongly inhibited by glutamate in cells expressing wild type mGlu(1) receptor, but no inhibition was detectable in neurons expressing mGlu(1)-dCT. These data indicate that C-terminal deletion of mGlu(1) receptor selectively abolishes Galpha(q/11) coupling.

{gamma}-Aminobutyric Acid and Glutamate Differentially Regulate Intracellular Calcium Concentrations in Mouse Gonadotropin-Releasing Hormone Neurons.

Endocrinology. 2009 Oct 28;
Constantin S, Jasoni CL, Wadas B, Herbison AE

Multiple factors regulate the activity of the GnRH neurons responsible for controlling fertility. Foremost among neuronal inputs to GnRH neurons are those using the amino acids glutamate and gamma-aminobutyric acid (GABA). The present study used a GnRH-Pericam transgenic mouse line, enabling live cell imaging of intracellular Calcium concentrations ([Ca(2+)]i) to evaluate the effects of glutamate and GABA signaling on [Ca(2+)]i in peripubertal and adult mouse GnRH neurons. Activation of GABAA, N-methyl-D-aspartate, or alpha-amino-3-hydroxyl-5-methyl-4-isoxazole propionate acid (AMPA) receptors was found to evoke an increase in [Ca(2+)]i, in subpopulations of GnRH neurons. Approximately 70% of GnRH neurons responded to GABA, regardless of postnatal age or sex. Many fewer ( approximately 20%) GnRH neurons responded to N-methyl-D-aspartate, and this was not influenced by postnatal age or sex. In contrast, about 65% of adult male and female GnRH neurons responded to AMPA compared with about 14% of male and female peripubertal mice (P < 0.05). The mechanisms underlying the ability of GABA and AMPA to increase [Ca(2+)]i in adult GnRH neurons were evaluated pharmacologically. Both GABA and AMPA were found to evoke [Ca(2+)]i increases through a Calcium-induced Calcium release mechanism involving internal Calcium stores and inositol-1,4,5-trisphosphate receptors. For GABA, the initial increase in [Ca(2+)]i originated from GABAA receptor-mediated activation of L-type voltage-gated Calcium channels, whereas for AMPA this appeared to involve direct Calcium entry through the AMPA receptor. These observations show that all of the principal amino acid receptors are able to control [Ca(2+)]i in GnRH neurons but that they do so in a postnatal age- and intracellular pathway-specific manner.

Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down.

BMC Genomics. 2009; 10(1): 499
Costa JL, Eijk PP, van de Wiel MA, Ten Berge D, Schmitt F, Narvaez CJ, Welsh J, Ylstra B

ABSTRACT: BACKGROUND: The active form of Vitamin D, 1,25-dihydroxyvitamin D3 (1,25D), has strong anti-proliferative effects, yet the molecular mechanisms underneath this effect remain unclear. In contrast, the molecular mechanism of 1,25D for the regulation of Calcium homeostasis has principally been resolved, demonstrating a pivotal role for the vitamin D receptor (VDR). RESULTS: We first addressed the question whether the anti-proliferative effects of 1,25D are influenced by VDR. Knockdown of VDR by siRNA did not affect the anti-proliferative effects of 1,25D in MCF7 breast cancer cells. This unanticipated finding led us to take an alternative approach using genome wide screens to study the molecular mechanisms of 1,25D in proliferation. For that purpose, four independently developed and stable 1,25D resistant MCF7 cell lines were analyzed. Array CGH identified a copy number alteration in a region of 13.5 Mb at chromosome 11q13.4-14.1 common to all four 1,25D resistant cell lines. Expression arrays revealed that no single gene was differentially expressed between the sensitive and resistant cells, but multiple membrane receptor signaling pathways were altered in the 1,25D resistant cell lines. Importantly, in the genome wide experiments neither VDR, CYP24A1 nor other known vitamin D signaling pathway genes were associated with 1,25D resistance. CONCLUSION: In conclusion, siRNA and genome wide studies both suggest that the anti-proliferative effects of 1,25D in MCF7 breast tumor cell lines do not rely on classical Vitamin D pathway per se.

Possible Contribution of 2-Aminoethoxydiphenyl-borate-Sensitive Ca(2+) Mobilization to Adrenocorticotropin-induced Glucocorticoid Synthesis in Rat Adrenocortical Cells.

Endocr J. 2009 Oct 23;
Hayashi C, Iino K, Oki Y, Matsushita F, Yamashita M, Yogo K, Sasaki S, Kumada T, Nakamura H

Cytoplasmic Calcium ([Ca(2+)](i)) provided through voltage-dependent Ca(2+)channels (VDCC) plays an important role in adrenocorticotropin (ACTH)-induced steroidogenesis in adrenocortical cells. To identify alternative mechanisms for [Ca(2+)]i supply, we investigated the 2-aminoethoxydiphenyl borate (2APB)-sensitive pathway as one of the possible signaling pathways involved in [Ca(2+)]i supply for ACTH-induced steroidogenesis. In monolayers of cultured rat adrenal fasciculate and reticularis cells, ACTH at 10(-11) M stimulated corticosterone synthesis without increasing intracellular cAMP, and corticosterone synthesis was decreased by 10muM 2APB by 51.8% (6.71 +/- 0.97 vs. 3.23 +/- 0.05 ng/mL/4hours; p<0.05). Furthermore, 2APB significantly decreased the 10(-11) M ACTH-stimulated [Ca(2+)](i). ACTH increased the intracellular inositol-1,4,5-trisphosphate (IP3) content with a peak at 10(-13) M ACTH, which illustrates the possibility that ACTH activates IP3/diacylglycerol- dependent protein kinase C signal transduction. However, the difference in ACTH concentrations between that responsible for the IP3 increase and steroidogenesis without elevated cAMP, suggest a hypothesis that IP3 is not required for steroidogenesis, but does involve an unknown messenger, which stimulates the release of Ca(2+) from the ER or the subsequent store-operated Ca(2+) entry (SOCE). The pregnenolone concentration in the culture medium was increased by ACTH, which was significantly suppressed by 2APB, showing that the 2APB-sensitive Ca(2+) supply affects cholesterol transport into the mitochondrial membrane via steroidogenic acute regulatory protein. Therefore, the SOCE may contribute to ACTH-induced steroidogenesis in the mitochondrial region. In conclusion, the [Ca(2+)](i) used for steroidogenesis may be derived from a 2APBsensitive pathway and via VDCCs, particularly at physiological concentrations of ACTH. We suggest that ACTH receptors activate steroidogenesis via inositol triphosphate, or an unknown downstream messenger, which could be inhibited by 2APB.